{"id":4925,"date":"2023-04-11T09:59:36","date_gmt":"2023-04-11T07:59:36","guid":{"rendered":"https:\/\/www.codex-partners.com\/?p=4925"},"modified":"2023-04-11T09:59:36","modified_gmt":"2023-04-11T07:59:36","slug":"codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group","status":"publish","type":"post","link":"https:\/\/www.codex-partners.com\/en\/deal-news-2\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\/","title":{"rendered":"CODEX Partners advises Harald Quandt Industriebeteiligungen on the acquisition of a majority stake in mediCAD Group"},"content":{"rendered":"\r\n<p class=\"wp-block-paragraph\">Harald Quandt Industriebeteiligungen GmbH (HQIB) acquired a majority interest in mediCAD SRB Software GmbH and its subsidiaries in March 2023. The previous owner, J\u00f6rn Seel, will remain shareholder and CEO of the group. The parties have agreed not to disclose further details of the transaction.<\/p>\r\n<p>mediCAD develops and distributes software for planning surgical operations in which joints are replaced (endoprosthetics) or preserved (traumatology and axis corrections). The product portfolio also includes innovative mixed reality solutions to support surgeons during operations and other value-added software tools. In total, nearly 3,000 hospitals and clinics and approximately 10,000 orthopedists and surgeons rely on mediCAD&#8217;s software solutions, which are approved in most parts of the world (FDA and MDR certified).<\/p>\r\n<p>CODEX Partners provided the <a href=\"https:\/\/www.codex-partners.com\/en\/expertise-and-services\/due-diligence\/\">Commercial Due Diligence<\/a> of mediCAD Group for HQIB.<\/p>\r\n<p>CODEX Partners advises investors on <a href=\"https:\/\/www.codex-partners.com\/en\/expertise-and-services\/due-diligence\/\">commercial due diligence<\/a> and <a href=\"https:\/\/www.codex-partners.com\/en\/expertise-and-services\/due-diligence\/commercial-vendor-due-diligence\/\">vendor due diligence<\/a>, strategy development, cost optimization, and restructuring of portfolio companies, as well as on developing industry platforms. Investors benefit from our experience of over 700 projects.<\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>Harald Quandt Industriebeteiligungen GmbH (HQIB) acquired a majority interest in mediCAD SRB Software GmbH and its subsidiaries in March 2023. The previous owner, J\u00f6rn Seel, will remain shareholder and CEO of the group. The parties have agreed not to disclose further details of the transaction. mediCAD develops and distributes software for planning surgical operations in<\/p>\n","protected":false},"author":7,"featured_media":3128,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[53],"tags":[82,149,190],"class_list":["post-4925","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-deal-news-2","tag-due-diligence-en","tag-software-en","tag-healthcare-en"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.2.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Discover how Codex Partners successfully advised HQIB on acquiring a majority stake in Medicad Group, enhancing healthcare investment opportunities\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Leonie Bobenstetter\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.codex-partners.com\/en\/deal-news-2\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.2.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"CODEX Partners Management Beratung - CODEX Partners ist eine f\u00fchrende Management Beratung f\u00fcr Mittelstands- und Beteiligungsunternehmen (Strategie, Organisation, Vertrieb, Kostensenkung, Umsetzung)\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Codex Partners Advises HQIB on Majority Stake in Medicad Group\" \/>\n\t\t<meta property=\"og:description\" content=\"Discover how Codex Partners successfully advised HQIB on acquiring a majority stake in Medicad Group, enhancing healthcare investment opportunities\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.codex-partners.com\/en\/deal-news-2\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2023-04-11T07:59:36+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2023-04-11T07:59:36+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Codex Partners Advises HQIB on Majority Stake in Medicad Group\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Discover how Codex Partners successfully advised HQIB on acquiring a majority stake in Medicad Group, enhancing healthcare investment opportunities\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/deal-news-2\\\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\\\/#blogposting\",\"name\":\"Codex Partners Advises HQIB on Majority Stake in Medicad Group\",\"headline\":\"CODEX Partners advises Harald Quandt Industriebeteiligungen on the acquisition of a majority stake in mediCAD Group\",\"author\":{\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/author\\\/lbobenstetter\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.codex-partners.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/pexels-kaboompics-com-6336.jpg\",\"width\":1600,\"height\":800},\"datePublished\":\"2023-04-11T09:59:36+02:00\",\"dateModified\":\"2023-04-11T09:59:36+02:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/deal-news-2\\\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/deal-news-2\\\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\\\/#webpage\"},\"articleSection\":\"Deal News, Due Diligence, Software, Healthcare, Optional\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/deal-news-2\\\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/category\\\/deal-news-2\\\/#listItem\",\"name\":\"Deal News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/category\\\/deal-news-2\\\/#listItem\",\"position\":2,\"name\":\"Deal News\",\"item\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/category\\\/deal-news-2\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/deal-news-2\\\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\\\/#listItem\",\"name\":\"CODEX Partners advises Harald Quandt Industriebeteiligungen on the acquisition of a majority stake in mediCAD Group\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/deal-news-2\\\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\\\/#listItem\",\"position\":3,\"name\":\"CODEX Partners advises Harald Quandt Industriebeteiligungen on the acquisition of a majority stake in mediCAD Group\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/category\\\/deal-news-2\\\/#listItem\",\"name\":\"Deal News\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/#organization\",\"name\":\"CODEX Partners Management Beratung\",\"description\":\"CODEX Partners ist eine f\\u00fchrende Management Beratung f\\u00fcr Mittelstands- und Beteiligungsunternehmen (Strategie, Organisation, Vertrieb, Kostensenkung, Umsetzung)\",\"url\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/author\\\/lbobenstetter\\\/#author\",\"url\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/author\\\/lbobenstetter\\\/\",\"name\":\"Leonie Bobenstetter\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/deal-news-2\\\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ef74f729d4b19f3db6156765f971709cdc6828f2fcb4bb4c2bb0dfe9546ff1c5?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Leonie Bobenstetter\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/deal-news-2\\\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\\\/#webpage\",\"url\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/deal-news-2\\\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\\\/\",\"name\":\"Codex Partners Advises HQIB on Majority Stake in Medicad Group\",\"description\":\"Discover how Codex Partners successfully advised HQIB on acquiring a majority stake in Medicad Group, enhancing healthcare investment opportunities\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/deal-news-2\\\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/author\\\/lbobenstetter\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/author\\\/lbobenstetter\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.codex-partners.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/pexels-kaboompics-com-6336.jpg\",\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/deal-news-2\\\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\\\/#mainImage\",\"width\":1600,\"height\":800},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/deal-news-2\\\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\\\/#mainImage\"},\"datePublished\":\"2023-04-11T09:59:36+02:00\",\"dateModified\":\"2023-04-11T09:59:36+02:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/\",\"name\":\"CODEX Partners Management Beratung\",\"description\":\"CODEX Partners ist eine f\\u00fchrende Management Beratung f\\u00fcr Mittelstands- und Beteiligungsunternehmen (Strategie, Organisation, Vertrieb, Kostensenkung, Umsetzung)\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.codex-partners.com\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Codex Partners Advises HQIB on Majority Stake in Medicad Group","description":"Discover how Codex Partners successfully advised HQIB on acquiring a majority stake in Medicad Group, enhancing healthcare investment opportunities","canonical_url":"https:\/\/www.codex-partners.com\/en\/deal-news-2\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.codex-partners.com\/en\/deal-news-2\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\/#blogposting","name":"Codex Partners Advises HQIB on Majority Stake in Medicad Group","headline":"CODEX Partners advises Harald Quandt Industriebeteiligungen on the acquisition of a majority stake in mediCAD Group","author":{"@id":"https:\/\/www.codex-partners.com\/en\/author\/lbobenstetter\/#author"},"publisher":{"@id":"https:\/\/www.codex-partners.com\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.codex-partners.com\/wp-content\/uploads\/2021\/04\/pexels-kaboompics-com-6336.jpg","width":1600,"height":800},"datePublished":"2023-04-11T09:59:36+02:00","dateModified":"2023-04-11T09:59:36+02:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/www.codex-partners.com\/en\/deal-news-2\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\/#webpage"},"isPartOf":{"@id":"https:\/\/www.codex-partners.com\/en\/deal-news-2\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\/#webpage"},"articleSection":"Deal News, Due Diligence, Software, Healthcare, Optional"},{"@type":"BreadcrumbList","@id":"https:\/\/www.codex-partners.com\/en\/deal-news-2\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.codex-partners.com\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/www.codex-partners.com\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.codex-partners.com\/en\/category\/deal-news-2\/#listItem","name":"Deal News"}},{"@type":"ListItem","@id":"https:\/\/www.codex-partners.com\/en\/category\/deal-news-2\/#listItem","position":2,"name":"Deal News","item":"https:\/\/www.codex-partners.com\/en\/category\/deal-news-2\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.codex-partners.com\/en\/deal-news-2\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\/#listItem","name":"CODEX Partners advises Harald Quandt Industriebeteiligungen on the acquisition of a majority stake in mediCAD Group"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.codex-partners.com\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.codex-partners.com\/en\/deal-news-2\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\/#listItem","position":3,"name":"CODEX Partners advises Harald Quandt Industriebeteiligungen on the acquisition of a majority stake in mediCAD Group","previousItem":{"@type":"ListItem","@id":"https:\/\/www.codex-partners.com\/en\/category\/deal-news-2\/#listItem","name":"Deal News"}}]},{"@type":"Organization","@id":"https:\/\/www.codex-partners.com\/en\/#organization","name":"CODEX Partners Management Beratung","description":"CODEX Partners ist eine f\u00fchrende Management Beratung f\u00fcr Mittelstands- und Beteiligungsunternehmen (Strategie, Organisation, Vertrieb, Kostensenkung, Umsetzung)","url":"https:\/\/www.codex-partners.com\/en\/"},{"@type":"Person","@id":"https:\/\/www.codex-partners.com\/en\/author\/lbobenstetter\/#author","url":"https:\/\/www.codex-partners.com\/en\/author\/lbobenstetter\/","name":"Leonie Bobenstetter","image":{"@type":"ImageObject","@id":"https:\/\/www.codex-partners.com\/en\/deal-news-2\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/ef74f729d4b19f3db6156765f971709cdc6828f2fcb4bb4c2bb0dfe9546ff1c5?s=96&d=mm&r=g","width":96,"height":96,"caption":"Leonie Bobenstetter"}},{"@type":"WebPage","@id":"https:\/\/www.codex-partners.com\/en\/deal-news-2\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\/#webpage","url":"https:\/\/www.codex-partners.com\/en\/deal-news-2\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\/","name":"Codex Partners Advises HQIB on Majority Stake in Medicad Group","description":"Discover how Codex Partners successfully advised HQIB on acquiring a majority stake in Medicad Group, enhancing healthcare investment opportunities","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/www.codex-partners.com\/en\/#website"},"breadcrumb":{"@id":"https:\/\/www.codex-partners.com\/en\/deal-news-2\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\/#breadcrumblist"},"author":{"@id":"https:\/\/www.codex-partners.com\/en\/author\/lbobenstetter\/#author"},"creator":{"@id":"https:\/\/www.codex-partners.com\/en\/author\/lbobenstetter\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.codex-partners.com\/wp-content\/uploads\/2021\/04\/pexels-kaboompics-com-6336.jpg","@id":"https:\/\/www.codex-partners.com\/en\/deal-news-2\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\/#mainImage","width":1600,"height":800},"primaryImageOfPage":{"@id":"https:\/\/www.codex-partners.com\/en\/deal-news-2\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\/#mainImage"},"datePublished":"2023-04-11T09:59:36+02:00","dateModified":"2023-04-11T09:59:36+02:00"},{"@type":"WebSite","@id":"https:\/\/www.codex-partners.com\/en\/#website","url":"https:\/\/www.codex-partners.com\/en\/","name":"CODEX Partners Management Beratung","description":"CODEX Partners ist eine f\u00fchrende Management Beratung f\u00fcr Mittelstands- und Beteiligungsunternehmen (Strategie, Organisation, Vertrieb, Kostensenkung, Umsetzung)","inLanguage":"en-US","publisher":{"@id":"https:\/\/www.codex-partners.com\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"CODEX Partners Management Beratung - CODEX Partners ist eine f\u00fchrende Management Beratung f\u00fcr Mittelstands- und Beteiligungsunternehmen (Strategie, Organisation, Vertrieb, Kostensenkung, Umsetzung)","og:type":"article","og:title":"Codex Partners Advises HQIB on Majority Stake in Medicad Group","og:description":"Discover how Codex Partners successfully advised HQIB on acquiring a majority stake in Medicad Group, enhancing healthcare investment opportunities","og:url":"https:\/\/www.codex-partners.com\/en\/deal-news-2\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\/","article:published_time":"2023-04-11T07:59:36+00:00","article:modified_time":"2023-04-11T07:59:36+00:00","twitter:card":"summary","twitter:title":"Codex Partners Advises HQIB on Majority Stake in Medicad Group","twitter:description":"Discover how Codex Partners successfully advised HQIB on acquiring a majority stake in Medicad Group, enhancing healthcare investment opportunities"},"aioseo_meta_data":{"post_id":"4925","title":"Codex Partners Advises HQIB on Majority Stake in Medicad Group","description":"Discover how Codex Partners successfully advised HQIB on acquiring a majority stake in Medicad Group, enhancing healthcare investment opportunities","keywords":[],"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":[],"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":{"id":"aioseo-article-637c18e320dd3","slug":"article","graphName":"Article","label":"Artikel","properties":{"type":"BlogPosting","name":"#post_title","headline":"#post_title","description":"#post_excerpt","image":"","keywords":"","author":{"name":"#author_name","url":"#author_url"},"dates":{"include":true,"datePublished":"","dateModified":""}}},"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":"{\"article\":{\"articleType\":\"BlogPosting\"},\"course\":{\"name\":\"\",\"description\":\"\",\"provider\":\"\"},\"faq\":{\"pages\":[]},\"product\":{\"reviews\":[]},\"recipe\":{\"ingredients\":[],\"instructions\":[],\"keywords\":[]},\"software\":{\"reviews\":[],\"operatingSystems\":[]},\"webPage\":{\"webPageType\":\"WebPage\"}}","pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":true,"ai":null,"created":"2023-04-11 07:55:47","updated":"2025-07-05 16:21:26","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.codex-partners.com\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.codex-partners.com\/en\/category\/deal-news-2\/\" title=\"Deal News\">Deal News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tCODEX Partners advises Harald Quandt Industriebeteiligungen on the acquisition of a majority stake in mediCAD Group\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.codex-partners.com\/en\/"},{"label":"Deal News","link":"https:\/\/www.codex-partners.com\/en\/category\/deal-news-2\/"},{"label":"CODEX Partners advises Harald Quandt Industriebeteiligungen on the acquisition of a majority stake in mediCAD Group","link":"https:\/\/www.codex-partners.com\/en\/deal-news-2\/codex-partners-advises-harald-quandt-industriebeteiligungen-on-the-acquisition-of-a-majority-stake-in-medicad-group\/"}],"_links":{"self":[{"href":"https:\/\/www.codex-partners.com\/en\/wp-json\/wp\/v2\/posts\/4925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.codex-partners.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.codex-partners.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.codex-partners.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.codex-partners.com\/en\/wp-json\/wp\/v2\/comments?post=4925"}],"version-history":[{"count":1,"href":"https:\/\/www.codex-partners.com\/en\/wp-json\/wp\/v2\/posts\/4925\/revisions"}],"predecessor-version":[{"id":4926,"href":"https:\/\/www.codex-partners.com\/en\/wp-json\/wp\/v2\/posts\/4925\/revisions\/4926"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.codex-partners.com\/en\/wp-json\/wp\/v2\/media\/3128"}],"wp:attachment":[{"href":"https:\/\/www.codex-partners.com\/en\/wp-json\/wp\/v2\/media?parent=4925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.codex-partners.com\/en\/wp-json\/wp\/v2\/categories?post=4925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.codex-partners.com\/en\/wp-json\/wp\/v2\/tags?post=4925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}